These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1362 related articles for article (PubMed ID: 27288918)

  • 41. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
    Hsieh TP; Sheu SY; Sun JS; Chen MH
    Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K
    Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
    Shim KS; Lee B; Ma JY
    BMC Complement Altern Med; 2017 Oct; 17(1):483. PubMed ID: 29070038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.
    Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y
    J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salicortin inhibits osteoclast differentiation and bone resorption by down-regulating JNK and NF-κB/NFATc1 signaling pathways.
    Nie S; Xu J; Zhang C; Xu C; Liu M; Yu D
    Biochem Biophys Res Commun; 2016 Jan; 470(1):61-67. PubMed ID: 26740180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.
    Kim AR; Kim HS; Lee JM; Choi JH; Kim SN; Kim DK; Kim JH; Mun SH; Kim JW; Jeon HS; Kim YM; Choi WS
    Eur J Pharmacol; 2012 May; 682(1-3):29-36. PubMed ID: 22387094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccaria hypaphorine impairs RANKL-induced osteoclastogenesis by inhibition of ERK, p38, JNK and NF-κB pathway and prevents inflammatory bone loss in mice.
    Chen H; Guo T; Wang D; Qin R
    Biomed Pharmacother; 2018 Jan; 97():1155-1163. PubMed ID: 29136954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double Stranded RNA-Dependent Protein Kinase is Necessary for TNF-α-Induced Osteoclast Formation In Vitro and In Vivo.
    Shinohara H; Teramachi J; Okamura H; Yang D; Nagata T; Haneji T
    J Cell Biochem; 2015 Sep; 116(9):1957-67. PubMed ID: 25739386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
    Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
    J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.
    Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH
    J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin 26 suppresses receptor activator of nuclear factor κB ligand induced osteoclastogenesis via down-regulation of nuclear factor of activated T-cells, cytoplasmic 1 and nuclear factor κB activity.
    Peng YJ; Wang CY; Lin YH; Lin GJ; Huang SH; Shyu JF; Sytwu HK; Cheng CP
    Rheumatology (Oxford); 2016 Nov; 55(11):2074-2083. PubMed ID: 27550297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the alendronate and irradiation with a light-emitting diode (LED) on murine osteoclastogenesis.
    Sohn HM; Ko Y; Park M; Kim B; Park JE; Kim D; Moon YL; Lim W
    Lasers Med Sci; 2017 Jan; 32(1):189-200. PubMed ID: 27807651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. l-tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK-TRAF6 interactions and inhibiting NF-κB and MAPK pathways.
    Zhi X; Wang L; Chen H; Fang C; Cui J; Hu Y; Cao L; Weng W; Zhou Q; Qin L; Song H; Wang Y; Wang Y; Jiang H; Li X; Wang S; Chen X; Su J
    J Cell Mol Med; 2020 Jan; 24(1):785-798. PubMed ID: 31725199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis.
    Guo RH; Kim SJ; Choi CH; Na CS; Kang BY; Kim YR
    BMC Complement Altern Med; 2019 Nov; 19(1):319. PubMed ID: 31747910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
    He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
    Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.
    Kim HJ; Yoon KA; Lee MK; Kim SH; Lee IK; Kim SY
    Life Sci; 2012 Nov; 91(19-20):928-34. PubMed ID: 23000100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynein light chain LC8 inhibits osteoclast differentiation and prevents bone loss in mice.
    Kim H; Hyeon S; Kim H; Yang Y; Huh JY; Park DR; Lee H; Seo DH; Kim HS; Lee SY; Jeong W
    J Immunol; 2013 Feb; 190(3):1312-8. PubMed ID: 23293355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.